The Patent Finder

Odyssey Thera Inc.

Also on record
Records under this name other than patents Odyssey Thera Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Odyssey Thera Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,101,364Fragments of fluorescent proteins for protein fragment complementation assays
Lapsed on the fee record
Ended Jan 24, 2020 · USPTO record
Lapsed on the fee recordEnded Jan 24, 2020USPTO record
US 7,989,218Protein fragment complementation assays for the detection of biological or drug interactions
Formerly held
Lapsed on the fee record
Ended Aug 2, 2019 · USPTO record
Lapsed on the fee recordEnded Aug 2, 2019USPTO record
US 7,306,914Protein fragment complementation assays in whole animals applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy
Term ended
Term ended Dec 7, 2018 · USPTO record
Term endedTerm ended Dec 7, 2018USPTO record
US 7,160,691Protein fragment complementation assays for the detection of biological or drug interactions
Formerly held
Term ended
Term ended Oct 14, 2018 · USPTO record
Term endedTerm ended Oct 14, 2018USPTO record
US 6,294,330Protein fragment complementation assays for the detection of biological or drug interactions
Term ended
Term ended Jul 30, 2018 · USPTO record
Term endedTerm ended Jul 30, 2018USPTO record
US 6,270,964Protein fragment complementation assays for the detection of biological or drug interactions
Term ended
Term ended Feb 2, 2018 · USPTO record
Term endedTerm ended Feb 2, 2018USPTO record
US 6,428,951Protein fragment complementation assays for the detection of biological or drug interactions
Formerly held
Term ended
Ended no later than Feb 2, 2018 · USPTO record
Term endedEnded no later than Feb 2, 2018USPTO record
US 7,166,424Fragments of fluorescent proteins for protein fragment complementation assays
Term ended
Term ended Feb 2, 2018 · USPTO record
Term endedTerm ended Feb 2, 2018USPTO record
US 8,192,944Protein fragment complementation assays for the detection of biological or drug interactions
Formerly held
Term ended
Ended no later than Feb 2, 2018 · USPTO record
Term endedEnded no later than Feb 2, 2018USPTO record
US 7,625,700In vivo library-versus-library selection of optimized protein-protein interactions
Lapsed on the fee record
Ended Dec 1, 2017 · USPTO record
Lapsed on the fee recordEnded Dec 1, 2017USPTO record
10 of 19 patents shown.
Pro members see all 19.
Pro members: see all 19 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited